Markets

Catheter Precision Receives FDA Clearance For Its VIVO System To Expand Labeling In Its Indications For Use Statement

Nov 2, 2026 · 08:10 AM ET· updated 1h ago

Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE American: VJET), today announced that its VIVO system has received FDA 510(k) clearance for expanded labeling in its Indications for Use

Why It Matters

Catheter Precision got approval to use its VIVO system for more medical situations. This shows the product is working and the company can reach more patients.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

VJET0.59

+0.00 (+0.51%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.